MedPath

COLLAGENASE SANTYL

COLLAGENASE SANTYL ointment 250 units/g [SMITH & NEPHEW, INC]

Approved
Approval ID

6b6fbfc6-98fa-46aa-88ef-ab00fbb08ffd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 17, 2019

Manufacturers
FDA

SMITH & NEPHEW, INC

DUNS: 827731451

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

COLLAGENASE SANTYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50484-010
Application NumberBLA101995
Product Classification
M
Marketing Category
C73585
G
Generic Name
COLLAGENASE SANTYL
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 24, 2017
FDA Product Classification

INGREDIENTS (2)

COLLAGENASE CLOSTRIDIUM HISTOLYTICUMActive
Quantity: 250 [arb'U] in 1 g
Code: 9X7O8V25IT
Classification: ACTIB
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COLLAGENASE SANTYL - FDA Drug Approval Details